| Literature DB >> 26253170 |
Li Huang1, Junjie Han2, Danya Ben-Hail3, Luwei He2, Baowei Li1, Ziheng Chen1, Yueying Wang1, Yanlei Yang1, Lei Liu1, Yushan Zhu4, Varda Shoshan-Barmatz5, Hongwei Liu6, Quan Chen7.
Abstract
The pro-apoptotic Bax and Bak proteins are considered central to apoptosis, yet apoptosis occurs in their absence. Here, we asked whether the mitochondrial protein VDAC1 mediates apoptosis independently of Bax/Bak. Upon screening a fungal secondary metabolite library for compounds inducing apoptosis in Bax/Bak-deficient mouse embryonic fibroblasts, we identified cyathin-R, a new cyathane diterpenoid compound able to activate apoptosis in the absence of Bax/Bak via promotion of the VDAC1 oligomerization that mediates cytochrome c release. Diphenylamine-2-carboxilic acid, an inhibitor of VDAC1 conductance and oligomerization, inhibited cyathin-R-induced VDAC1 oligomerization and apoptosis. Similarly, Bcl-2 overexpression conferred resistance to cyathin-R-induced apoptosis and VDAC1 oligomerization. Silencing of VDAC1 expression prevented cyathin-R-induced apoptosis. Finally, cyathin-R effectively attenuated tumor growth and induced apoptosis in Bax/Bak-deficient cells implanted into a xenograft mouse model. Hence, this study identified a new compound promoting VDAC1-dependent apoptosis as a potential therapeutic option for cancerous cells lacking or presenting inactivated Bax/Bak.Entities:
Keywords: B-cell lymphoma 2 (Bcl-2); Bax; Bcl2; cyathane diterpenoid; mitochondrial apoptosis; oligomerization; protein cross-linking; voltage-dependent anion channel (VDAC)
Mesh:
Substances:
Year: 2015 PMID: 26253170 PMCID: PMC4583032 DOI: 10.1074/jbc.M115.648774
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157